Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
RISEDRONATE SODIUM
Warner Chilcott UK Limited
M05BA07
RISEDRONATE SODIUM
75 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Bisphosphonates
Authorised
2010-04-30
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT OPTINATE 75 MG FILM-COATED TABLETS risedronate sodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Optinate is and what it is used for 2. What you need to know before you take Optinate 3. How to take Optinate 4. Possible side effects 5. How to store Optinate 6. Contents of the pack and other information 1. WHAT OPTINATE IS AND WHAT IT IS USED FOR WHAT OPTINATE IS Optinate belongs to a group of non-hormonal medicines called bisphosphonates which are used to treat bone diseases. It works directly on your bones to make them stronger and therefore less likely to break. Bone is a living tissue. Old bone is constantly removed from your skeleton and replaced with new bone. Postmenopausal osteoporosis is a condition occurring in women after the menopause where the bones become weaker, more fragile and more likely to break after a fall or strain. The spine, hip and wrist are the most likely bones to break, although this can happen to any bone in your body. Osteoporosis-related fractures can also cause back pain, height loss and a curved back. Many patients with osteoporosis have no symptoms and you may not even have known that you had it. WHAT OPTINATE IS USED FOR The treatment of osteoporosis in postmenopausal women. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE OPTINATE DO NOT TAKE OPTINATE If you are allergic to risedronate sodium or any of the other ingredients of this medicine (listed in section 6) If your doctor has told you that you have a Olvassa el a teljes dokumentumot
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Optinate 75mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film - coated tablet contains 75 mg risedronate sodium (equivalent to 69.6 mg risedronic acid). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film - coated tablet. Oval pink 11.7 x 5.8 mm film - coated tablet engraved with RSN on one side and 75 mg on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of osteoporosis in postmenopausal women at increased risk of fractures (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The recommended dose in adults is one 75 mg tablet orally on two consecutive days a month. The first tablet should be taken on the same day each month, followed by the second tablet the next day. Method of administration • The absorption of risedronate sodium is affected by food and polyvalent cations (see section 4.5), thus to ensure adequate absorption patients should take Optinate 75 mg before breakfast: at least 30 minutes before the first food, other medicinal product or drink (other than plain water) of the day. Plain water is the only drink that should be taken with Optinate 75 mg tablet. Please note that some mineral water may have a higher concentration of calcium and therefore should not be used (see section 5.2). • Patients who miss a dose of Optinate 75 mg should be instructed to take one Optinate 75 mg tablet the morning after the day it is remembered, unless the time to the next month’s scheduled doses are within 7 days. Patients should then return to taking Optinate 75 mg tablet on two consecutive days a month on the day the tablet is normally taken. • If the next month’s scheduled doses Optinate 75 mg are within 7 days, patients should wait until their next month’s scheduled doses and then continue taking Optinate 75 mg on two consecutive days each month as originally scheduled. • Three tablets should not be taken in the same week. The tablet must be swall Olvassa el a teljes dokumentumot